Home › Funds › Eschler Asset Management LLP › IMCR

Eschler Asset Management LLP position in IMCR

IMMUNOCORE HLDGS PLC · Health Care

Eschler Asset Management LLP reported holding 100,000 shares of IMCR (IMMUNOCORE HLDGS PLC) in its Q3 2026 13F filing — a position valued at US$3.0M, representing 3.56% of its reported portfolio and ranking #9 among its reported holdings. Eschler Asset Management LLP has disclosed IMCR holdings in 9 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)100.00K sh
Reported value held$3.03M
Portfolio Weight3.56%
First reportedQ3 2023
Last changeNew
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Eschler Asset Management LLP's IMCR position evolved

Eschler Asset Management LLP first disclosed a stake in IMCR in Q3 2023 at 30,000 shares (US$1.6M). The position peaked in Q3 2026 at 100,000 shares, worth US$3.0M. Across 9 filings, Eschler Asset Management LLP increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 100,000 shares valued at US$3.0M. Notable position changes include a 33% increase in Q4 2023 (shares fell 5% over the following quarter), a 100% increase in Q4 2025 (shares fell 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 30.00K $1.56M New
Q4 2023 40.00K $2.73M Add
Q1 2024 40.00K $2.60M Hold
Q2 2024 40.00K $2.60M Hold
Q2 2025 40.00K $1.26M New
Q3 2025 40.00K $1.45M Hold
Q4 2025 80.00K $2.78M Add
Q1 2026 80.00K $2.41M Hold
Q3 2026 100.00K $3.03M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IMCR and 13F data

IMCR (IMMUNOCORE HLDGS PLC) is a Health Care company. 27 other funds we track also report a position in IMCR — the largest reported positions include RTW INVESTMENTS, LP (US$147.5M), Bellevue Group AG (US$88.5M), TANG CAPITAL MANAGEMENT LLC (US$84.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IMCR

All IMCR fund holders →

FAQ

How long has Eschler Asset Management LLP held IMCR?

Eschler Asset Management LLP has disclosed IMCR holdings in 9 of the last 13 reported quarters, going back to Q3 2023.

What is Eschler Asset Management LLP's current position in IMCR?

As of Q3 2026, Eschler Asset Management LLP holds 100.00K shares of IMCR (IMMUNOCORE HLDGS PLC), valued at $3.03M, representing 3.56% of its reported portfolio and ranking #9.

Has Eschler Asset Management LLP been buying or selling IMCR?

In the latest 13F filing (Q3 2026), Eschler Asset Management LLP newly opened its position in IMCR. The position peaked in Q3 2026 at 100.00K shares.

Which other funds hold IMCR?

Other major institutional holders of IMCR include RTW INVESTMENTS, LP, Bellevue Group AG, TANG CAPITAL MANAGEMENT LLC, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.